The 2020 Congress aims to bring together leading academic scientists, researchers and medical clinicians from all fields of oncology to exchange and share their experiences and research results with emphasis on tumour markers and their role in diagnosis and therapy.
Relevant new findings in research, diagnosis and clinical Oncology – as well as technical developments, standardization and quality control, will be presented by opinion leaders in Oral and Poster presentations, along with panel discussions and special topic seminars. In addition, as during recent years, the EGTM (European Group of Tumour Markers) will present their Guidelines on optimal use of Tumour Markers and their clinical interpretation.
These details will be asked of you once you start the submission process. Please review this list and make sure you have all the required answers before starting the submission process.
Abstract Title — do not exceede the 150 characters upper limit (approx. 20-25 words).
Authors and Affiliations:
Body of abstract — limited to a maximum of 360 words. Abbreviations must be defined upon first use and avoided in the title.
The Abstract format should include:
Keywords — this call for papers does not accept keywords with submissions.
Classification — Please choose the appropriate topic (closest to your field of research your work belongs to) in order to aid the review process and programme formation.
Please indicate your preferred type of presentation:
Invitation letter for Visa required (presenting author):
International abstract submitters who plan to attend the 46th ISOBM Congress may need to apply for a VISA to travel to the meeting in Bled, Slovenia (EU). For more information on visa requirements, please go to https://www.schengenvisainfo.com/. Please be aware that the time required to obtain a VISA may be substantial. A letter confirming the Presenting author is to present at the Congress will be sent to abstract submitters that have checked “Yes” that a letter is needed.